James Foley’s love of the web started at an early age. An introduction to HTML by his middle school IT teacher was all the inspiration that he needed. Taking his studies into his spare time James quickly learned to code HTML and it wasn’t long before he was building websites.

The team discovered that, when CUX1 is deactivated, a biological pathway is activated that increases tumour growth.

Morgan cars are famous the world over for their charisma, quality materials, craftsmanship and performance (and of course speed!)

HiFDA and Novartis Healthcare Philippines have “determined that there are illegally imported and unregistered Purified Chick Embryo Cell (Rabipur) Rabies Vaccine being offered fo

ACT is urging supporters to join them in making a difference for patients this Christmas by giving a donation to the ‘ACT on Cancer’ campaign.

Following post-doctoral research at The University of Tokyo, The Weizmann Institute and The University of Cambridge, Marian has held a number of R&D related roles at several biotechology companies, such as Akubio, Unipath and DxTech, and a leading technology development consultancy.

Looking for something specific?

James Foley’s love of the web started at an early age. An introduction to HTML by his middle school IT teacher was all the inspiration that he needed. Taking his studies into his spare time James quickly learned to code HTML and it wasn’t long before he was building websites.

The team discovered that, when CUX1 is deactivated, a biological pathway is activated that increases tumour growth.

Morgan cars are famous the world over for their charisma, quality materials, craftsmanship and performance (and of course speed!)

HiFDA and Novartis Healthcare Philippines have “determined that there are illegally imported and unregistered Purified Chick Embryo Cell (Rabipur) Rabies Vaccine being offered fo

ACT is urging supporters to join them in making a difference for patients this Christmas by giving a donation to the ‘ACT on Cancer’ campaign.

Following post-doctoral research at The University of Tokyo, The Weizmann Institute and The University of Cambridge, Marian has held a number of R&D related roles at several biotechology companies, such as Akubio, Unipath and DxTech, and a leading technology development consultancy.